Latest News for GNMSF
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems' ability to convert a strong backlog and increasingly sophisticated project mix into sustained earnings growth. We did not make any adjustments to the position and continue to believe that the market opportunity remains robust.
Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript
Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for GNMSF.
Senate Trading
No Senate trades found for GNMSF.
U.S. House Trading
No House trades found for GNMSF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.